TANI, MONICA
TANI, MONICA
Alma Mater Studiorum Universita' di Bologna
18 F-FDG PET in malignant lymphoma: significance of positive findings
2005 Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S.
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
2006 Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsad M; Franchi R; Fanti S; Zinzani PL.
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
2008 Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M.
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET.
2008 Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D.; Tani M.; Zinzani P.L.; Fanti S.
Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients.
2006 Alinari L.; Ambrosini V.; Castellucci P.; Tani M.; Stefoni V.; Nanni C.; Farsad M.; Rubello D.; Franchi R.; Zinzani P.L.; Fanti S.
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
2006 Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Fili C; Tani M; Baccarani M; Fanin R.
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
2006 Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M.
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.
2008 Fanti S.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.L.; Franchi R.
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma.
2004 Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M.
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
2005 Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Zinzani PL.
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231).
2007 Isidori A.; Tani M.; Bonifazi F.; Zinzani P.; Curti A.; Motta M.R.; Rizzi S.; Giudice V.; Farese O.; Rovito M.; Alinari L.; Conte R.; Baccarani M.; Lemoli R.M.
FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma.
2010 Lopci E; Santi I; Tani M; Maffione AM; Montini G; Castellucci P; Stefoni V; Rubello D; Fonti C; Zinzani P; Fanti S.
FDG-PET in the serial assessment of patinets with lymphoma in complete remission
2007 V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari; D. Rubello; R. Franchi; S. Fanti
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
2008 Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M.
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma.
2005 Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Rupoli S; Pileri S; Baccarani M; Zinzani PL
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience
2004 ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M.
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
2007 Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M.
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
2005 ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. |
Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsa...d M; Franchi R; Fanti S; Zinzani PL. |
2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. | Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D....; Tani M.; Zinzani P.L.; Fanti S. | 2008-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients. | Alinari L.; Ambrosini V.; Castellucci P.; Tani M.; Stefoni V.; Nanni C.; Farsad M.; Rubello D.; F...ranchi R.; Zinzani P.L.; Fanti S. | 2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia. | Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Fili C; Tani M; Baccarani M;... Fanin R. | 2006-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. | Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; F...ina M.; Farshad M.; Pileri S.; Baccarani M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. | Fanti S.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.L.; ...Franchi R. | 2008-01-01 | ANNALS OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. | Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani... M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. |
Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Z...inzani PL. |
2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). | Isidori A.; Tani M.; Bonifazi F.; Zinzani P.; Curti A.; Motta M.R.; Rizzi S.; Giudice V.; Farese ...O.; Rovito M.; Alinari L.; Conte R.; Baccarani M.; Lemoli R.M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma. | Lopci E; Santi I; Tani M; Maffione AM; Montini G; Castellucci P; Stefoni V; Rubello D; Fonti C; Z...inzani P; Fanti S. | 2010-01-01 | THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| FDG-PET in the serial assessment of patinets with lymphoma in complete remission | V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari;... D. Rubello; R. Franchi; S. Fanti | 2007-01-01 | - | Society of Nuclear Medicine | 4.02 Riassunto (Abstract) | - |
| Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ). |
Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fat...tori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M. |
2008-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Gemcitabine as frontline treatment for cutaneous T-cell lymphoma. |
Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Ru...poli S; Pileri S; Baccarani M; Zinzani PL |
2005-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience | ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M....; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. | Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpia...z G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. | ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MAR...CHI E; FALINI B; BACCARANI M; PILERI SA. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |